in support of the 'retroviral hypothesis' but dismayed to see that the authors had omitted to mention or reference the highly relevant and extensive pre-existing literature of at least thirty papers linking multiple sclerosis with this retroviral family. [2] [3] [4] [5] [6] [7] [8] [9] [10] Syncytin (enverin) is the envelope glycoprotein of a defective provirus (ERVWE1) belonging to the human endogenous retrovirus HERV-W family, originally defined by its founder member the multiple sclerosis associated retrovirus, MSRV.
2 By omitting to mention explicitly that syncytin is closely related to the MSRV envelope protein, the authors give the impression that the observed association with multiple sclerosis is a novel finding.
The earliest paper connecting MSRV (referred to as LM7 prior to 1997) and multiple sclerosis was Intriguingly, a gliotoxin which destroys oligodendrocytes but not neurones has been identified in association with MSRV in CSF and monocyte/macrophage culture supernatants from MS patients. 5 This gliotoxic activity may or may not be related to the oligodendrocyte destroying syncytininduced cytotoxic conditioned medium described by Antony et al. It is also relevant to note here that the MSRV envelope glycoprotein, either recombinant or virionderived, displays superantigen properties 4 associated with the production of pro-inflammatory cytokines. Furthermore, the potent pro-inflammatory properties and T cell-mediated immunopathogenic potential of MSRV virions have been dramatically demonstrated in vivo using a humanized SCID mouse model. 6 
2
We believe that the excellent work of Antony and colleagues 1 represents a significant advance in our understanding and confirms the importance of this rapidly developing field in human pathobiology. We trust that this letter provides the essential conceptual background to the work and serves to put the new findings into their appropriate historical context.
